These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7960200)

  • 1. Evaluation of blood ammonia alterations in uremic patients under hemodialysis and CAPD.
    Agroyannis B; Tzanatos H; Chondros K; Fourtounas C; Kopelias I; Bougatsos G; Voudiclaris S; Koutsikos D
    Int J Artif Organs; 1994 May; 17(5):307-8. PubMed ID: 7960200
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of end-stage renal disease and dialysis modalities on blood ammonia level.
    Vaziri ND; Khazaeli M; Nunes ACF; Harley KT; Said H; Alipour O; Lau WL; Pahl MV
    Hemodial Int; 2017 Jul; 21(3):343-347. PubMed ID: 27804262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neutrophil function of uremic patients treated by hemodialysis or CAPD.
    Huttunen K; Lampainen E; Silvennoinen-Kassinen S; Tiilikainen A
    Scand J Urol Nephrol; 1984; 18(2):167-72. PubMed ID: 6463600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of erythropoiesis in uremic patients on CAPD.
    Lamperi S; Carozzi S; Icardi A
    Int J Artif Organs; 1983 Jul; 6(4):191-4. PubMed ID: 6629524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of arterial blood ammonia in uremic patients before and after hemodialysis using three different ammonia methods.
    Huizenga JR; Mulder B; Stegeman CA; Ament W; Teelken AW
    Artif Organs; 2002 Sep; 26(9):815-6; author reply 816. PubMed ID: 12197941
    [No Abstract]   [Full Text] [Related]  

  • 6. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells.
    Mettang T; Fritz P; Weber J; Machleidt C; Hübel E; Kuhlmann U
    Clin Nephrol; 1990 Sep; 34(3):136-41. PubMed ID: 1699691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Branched chain and aromatic free amino acids in plasma and skeletal muscle of uremic patients undergoing hemodialysis and CAPD.
    Graziani G; Cantaluppi A; Casati S; Citterio A; Ponticelli C; Trifirò A; Borghi L; Sani E; Simoni I; Montanari A
    Int J Artif Organs; 1984 Mar; 7(2):85-8. PubMed ID: 6735500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of phospholipids asymmetry in red blood cells contributes to anemia in uremic patients.
    Kong QY; Wu X; Li J; Peng WX; Ye R; Lindholm B; Wang T
    Adv Perit Dial; 2001; 17():58-60. PubMed ID: 11510298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immune status of the uremic patient: hemodialysis vs CAPD.
    Schollmeyer P; Bozkurt F
    Clin Nephrol; 1988; 30 Suppl 1():S37-40. PubMed ID: 3052959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arteriovenous difference of blood ammonia in uremic patients under hemodialysis.
    Agroyannis B; Tzanatos H; Fourtounas C; Kopelias I; Katsoudas S; Chondros K
    Artif Organs; 1998 Aug; 22(8):703-5. PubMed ID: 9702323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal platelet cytoskeletal assembly in hemodialyzed patients results in deficient tyrosine phosphorylation signaling.
    Díaz-Ricart M; Estebanell E; Cases A; Calls J; López-Pedret J; Carretero M; Castillo R; Ordinas A; Escolar G
    Kidney Int; 2000 May; 57(5):1905-14. PubMed ID: 10792609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
    Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH
    J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.
    Marcovici O; Boner G; Rosenfeld JB
    Isr J Med Sci; 1983 Jul; 19(7):604-7. PubMed ID: 6885343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA metabolism in uremic patients: accumulation of modified ribonucleosides in uremic serum. Technical note.
    Niwa T; Takeda N; Yoshizumi H
    Kidney Int; 1998 Jun; 53(6):1801-6. PubMed ID: 9607216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uremic neuropathy and the type of dialysis].
    Firenze C; Gallai V; Mattelli L; Mazzotta G; Panzetta AM; Buoncristiani U
    Riv Patol Nerv Ment; 1982; 103(6):271-6. PubMed ID: 6326249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin and uremic toxicity during continuous ambulatory peritoneal dialysis.
    Wideröe TE; Sanengen T; Halvorsen S
    Kidney Int Suppl; 1983 Dec; 16():S208-17. PubMed ID: 6588251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protein-bound uremic toxins: efficacy of elimination during hemodialysis and CAPD].
    Krajewska M; Weyde W; Klinger M
    Pol Arch Med Wewn; 2003 Apr; 109(4):411-5. PubMed ID: 12931494
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced blood levels of coagulation inhibitors in chronic hemodialysis compared with CAPD.
    Bertoli SV; di Belgiojoso GB; Trezzi M; Scorza D; Barone MT; Poggio M; Rossi E; Landriani N; Genderini A
    Adv Perit Dial; 1995; 11():127-30. PubMed ID: 8534685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of middle molecules in uremic patients.
    Wu ZG; Cai ZH; Lu ZN; Liao LT; Zhu SQ
    Chin Med J (Engl); 1985 Feb; 98(2):115-20. PubMed ID: 3922688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.